Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease-Reference-Cited by-同舟云学术

Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease

Published:2022-02-08 Issue:5 Volume:37 Page:795-811
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Chan Wah‐Kheong¹^ORCID,Tan Soek‐Siam²,Chan Siew‐Pheng³,Lee Yeong‐Yeh⁴^ORCID,Tee Hoi‐Poh⁵,Mahadeva Sanjiv¹^ORCID,Goh Khean‐Lee¹^ORCID,Ramli Anis Safura⁶⁷,Mustapha Feisul⁸,Kosai Nik Ritza⁹,Raja Ali Raja Affendi¹⁰

Affiliation:

1. Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

2. Department of Hepatology Selayang Hospital Batu Caves Selangor Malaysia

3. Subang Jaya Medical Centre Subang Jaya Selangor Malaysia

4. School of Medical Sciences Universiti Sains Malaysia Kota Bharu Kelantan Malaysia

5. KPJ Pahang Specialist Centre Kuantan Pahang Malaysia

6. Department of Primary Care Medicine, Faculty of Medicine Universiti Teknologi MARA, Selayang Campus Batu Caves Selangor Malaysia

7. Institute of Pathology, Laboratory and Forensic Medicine, Centre of Excellence for Research on Atherosclerosis and CVD Prevention Universiti Teknologi MARA, Sungai Buloh Campus Sungai Buloh Selangor Malaysia

8. Disease Control Division Ministry of Health, Malaysia Putrajaya Malaysia

9. Upper Gastrointestinal, Metabolic and Bariatric Surgery Unit, Department of Surgery Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia

10. Gastroenterology Unit, Department of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15787

Reference153 articles.

1. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

2. From NAFLD to MAFLD : Implications of a Premature Change in Terminology

3. What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’

4. Metabolic‐associated fatty liver disease: time to integrate ground‐breaking new terminology to our clinical practice?;Demirtas CO;Hepatology Forum,2020

5. On the Proposed Definition of Metabolic-Associated Fatty Liver Disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis;Journal of Gastroenterology and Hepatology;2024-08-16

2. Liver dysfunction in adults with COVID‐19 infection: A longitudinal study with transient elastography evaluation;JGH Open;2024-08

3. Correspondence: “A multisociety Delphi consensus statement on new fatty liver disease nomenclature”;Annals of Hepatology;2024-07

4. LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease;Journal of Gastroenterology and Hepatology;2024-07

5. MAFLD: from a disease framework to patient care;Hepatology International;2024-06-17